Go Pro

SS Innovations International (SSII) Competitors

SS Innovations International logo
$3.59 -0.02 (-0.55%)
As of 08/21/2026 04:00 PM Eastern

SSII vs. PLSE, TMDX, AXGN, ESTA, and BFLY

Should you buy SS Innovations International stock or one of its competitors? SS Innovations International's main competitors and comparable companies include Pulse Biosciences (PLSE), TransMedics Group (TMDX), AxoGen (AXGN), Establishment Labs (ESTA), and Butterfly Network (BFLY). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does SS Innovations International compare to Pulse Biosciences?

SS Innovations International (NASDAQ:SSII) and Pulse Biosciences (NASDAQ:PLSE) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, valuation, earnings, profitability, dividends, risk, analyst recommendations and institutional ownership.

SS Innovations International has a beta of -1.92, meaning that its stock price is 292% less volatile than the broader market. Comparatively, Pulse Biosciences has a beta of 1.61, meaning that its stock price is 61% more volatile than the broader market.

SS Innovations International presently has a consensus target price of $7.00, indicating a potential upside of 94.99%. Pulse Biosciences has a consensus target price of $45.25, indicating a potential downside of 10.25%. Given SS Innovations International's higher probable upside, equities research analysts plainly believe SS Innovations International is more favorable than Pulse Biosciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SS Innovations International
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Pulse Biosciences
1 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.60

In the previous week, Pulse Biosciences had 3 more articles in the media than SS Innovations International. MarketBeat recorded 8 mentions for Pulse Biosciences and 5 mentions for SS Innovations International. Pulse Biosciences' average media sentiment score of 0.86 beat SS Innovations International's score of 0.44 indicating that Pulse Biosciences is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
SS Innovations International
2 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Pulse Biosciences
3 Very Positive mention(s)
3 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

SS Innovations International has higher revenue and earnings than Pulse Biosciences. SS Innovations International is trading at a lower price-to-earnings ratio than Pulse Biosciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SS Innovations International$42.49M16.93-$12.13M-$0.06N/A
Pulse Biosciences$350K9,970.19-$72.78M-$1.18N/A

77.0% of Pulse Biosciences shares are held by institutional investors. 74.0% of Pulse Biosciences shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

SS Innovations International has a net margin of -23.73% compared to Pulse Biosciences' net margin of -6,755.78%. SS Innovations International's return on equity of -26.77% beat Pulse Biosciences' return on equity.

Company Net Margins Return on Equity Return on Assets
SS Innovations International-23.73% -26.77% -15.01%
Pulse Biosciences -6,755.78%-94.42%-79.96%

Summary

Pulse Biosciences beats SS Innovations International on 9 of the 16 factors compared between the two stocks.

How does SS Innovations International compare to TransMedics Group?

TransMedics Group (NASDAQ:TMDX) and SS Innovations International (NASDAQ:SSII) are both healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, valuation, media sentiment, analyst recommendations and dividends.

In the previous week, TransMedics Group had 6 more articles in the media than SS Innovations International. MarketBeat recorded 11 mentions for TransMedics Group and 5 mentions for SS Innovations International. TransMedics Group's average media sentiment score of 0.63 beat SS Innovations International's score of 0.44 indicating that TransMedics Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
TransMedics Group
5 Very Positive mention(s)
1 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
SS Innovations International
2 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

TransMedics Group has a beta of 1.9, suggesting that its stock price is 90% more volatile than the broader market. Comparatively, SS Innovations International has a beta of -1.92, suggesting that its stock price is 292% less volatile than the broader market.

TransMedics Group has higher revenue and earnings than SS Innovations International. SS Innovations International is trading at a lower price-to-earnings ratio than TransMedics Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TransMedics Group$605.49M5.41$190.29M$3.8924.36
SS Innovations International$42.49M16.93-$12.13M-$0.06N/A

99.7% of TransMedics Group shares are owned by institutional investors. 6.9% of TransMedics Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

TransMedics Group has a net margin of 22.69% compared to SS Innovations International's net margin of -23.73%. TransMedics Group's return on equity of 15.88% beat SS Innovations International's return on equity.

Company Net Margins Return on Equity Return on Assets
TransMedics Group22.69% 15.88% 5.95%
SS Innovations International -23.73%-26.77%-15.01%

TransMedics Group currently has a consensus target price of $124.18, indicating a potential upside of 31.03%. SS Innovations International has a consensus target price of $7.00, indicating a potential upside of 94.99%. Given SS Innovations International's higher possible upside, analysts clearly believe SS Innovations International is more favorable than TransMedics Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
TransMedics Group
1 Sell rating(s)
6 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.38
SS Innovations International
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Summary

TransMedics Group beats SS Innovations International on 14 of the 16 factors compared between the two stocks.

How does SS Innovations International compare to AxoGen?

SS Innovations International (NASDAQ:SSII) and AxoGen (NASDAQ:AXGN) are both healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, profitability, dividends, earnings, analyst recommendations, valuation and risk.

SS Innovations International has higher earnings, but lower revenue than AxoGen. AxoGen is trading at a lower price-to-earnings ratio than SS Innovations International, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SS Innovations International$42.49M16.93-$12.13M-$0.06N/A
AxoGen$225.21M12.03-$15.70M-$0.68N/A

SS Innovations International presently has a consensus price target of $7.00, indicating a potential upside of 94.99%. AxoGen has a consensus price target of $51.00, indicating a potential upside of 1.19%. Given SS Innovations International's higher possible upside, equities research analysts clearly believe SS Innovations International is more favorable than AxoGen.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SS Innovations International
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
AxoGen
1 Sell rating(s)
1 Hold rating(s)
9 Buy rating(s)
0 Strong Buy rating(s)
2.73

In the previous week, AxoGen had 1 more articles in the media than SS Innovations International. MarketBeat recorded 6 mentions for AxoGen and 5 mentions for SS Innovations International. AxoGen's average media sentiment score of 1.51 beat SS Innovations International's score of 0.44 indicating that AxoGen is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
SS Innovations International
2 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
AxoGen
5 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

SS Innovations International has a beta of -1.92, suggesting that its share price is 292% less volatile than the broader market. Comparatively, AxoGen has a beta of 1.11, suggesting that its share price is 11% more volatile than the broader market.

AxoGen has a net margin of -13.36% compared to SS Innovations International's net margin of -23.73%. AxoGen's return on equity of -8.90% beat SS Innovations International's return on equity.

Company Net Margins Return on Equity Return on Assets
SS Innovations International-23.73% -26.77% -15.01%
AxoGen -13.36%-8.90%-6.47%

80.3% of AxoGen shares are owned by institutional investors. 2.4% of AxoGen shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

AxoGen beats SS Innovations International on 11 of the 16 factors compared between the two stocks.

How does SS Innovations International compare to Establishment Labs?

SS Innovations International (NASDAQ:SSII) and Establishment Labs (NASDAQ:ESTA) are both healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, risk, valuation, dividends, analyst recommendations, profitability, media sentiment and earnings.

Establishment Labs has a net margin of -15.82% compared to SS Innovations International's net margin of -23.73%. SS Innovations International's return on equity of -26.77% beat Establishment Labs' return on equity.

Company Net Margins Return on Equity Return on Assets
SS Innovations International-23.73% -26.77% -15.01%
Establishment Labs -15.82%-196.69%-10.73%

SS Innovations International has a beta of -1.92, suggesting that its share price is 292% less volatile than the broader market. Comparatively, Establishment Labs has a beta of 1.07, suggesting that its share price is 7% more volatile than the broader market.

SS Innovations International presently has a consensus target price of $7.00, indicating a potential upside of 94.99%. Establishment Labs has a consensus target price of $100.25, indicating a potential upside of 37.95%. Given SS Innovations International's higher probable upside, analysts clearly believe SS Innovations International is more favorable than Establishment Labs.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SS Innovations International
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Establishment Labs
1 Sell rating(s)
0 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.78

72.9% of Establishment Labs shares are held by institutional investors. 10.0% of Establishment Labs shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

SS Innovations International has higher earnings, but lower revenue than Establishment Labs. SS Innovations International is trading at a lower price-to-earnings ratio than Establishment Labs, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SS Innovations International$42.49M16.93-$12.13M-$0.06N/A
Establishment Labs$211.08M10.26-$51.06M-$1.31N/A

In the previous week, SS Innovations International had 1 more articles in the media than Establishment Labs. MarketBeat recorded 5 mentions for SS Innovations International and 4 mentions for Establishment Labs. Establishment Labs' average media sentiment score of 0.99 beat SS Innovations International's score of 0.44 indicating that Establishment Labs is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
SS Innovations International
2 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Establishment Labs
3 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Establishment Labs beats SS Innovations International on 10 of the 16 factors compared between the two stocks.

How does SS Innovations International compare to Butterfly Network?

Butterfly Network (NYSE:BFLY) and SS Innovations International (NASDAQ:SSII) are both healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, analyst recommendations, profitability, valuation, institutional ownership, dividends, risk and earnings.

SS Innovations International has lower revenue, but higher earnings than Butterfly Network. SS Innovations International is trading at a lower price-to-earnings ratio than Butterfly Network, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Butterfly Network$97.61M25.92-$77.06M-$0.29N/A
SS Innovations International$42.49M16.93-$12.13M-$0.06N/A

37.9% of Butterfly Network shares are owned by institutional investors. 22.0% of Butterfly Network shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Butterfly Network had 2 more articles in the media than SS Innovations International. MarketBeat recorded 7 mentions for Butterfly Network and 5 mentions for SS Innovations International. Butterfly Network's average media sentiment score of 1.40 beat SS Innovations International's score of 0.44 indicating that Butterfly Network is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Butterfly Network
5 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
SS Innovations International
2 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

SS Innovations International has a net margin of -23.73% compared to Butterfly Network's net margin of -66.74%. SS Innovations International's return on equity of -26.77% beat Butterfly Network's return on equity.

Company Net Margins Return on Equity Return on Assets
Butterfly Network-66.74% -33.99% -22.96%
SS Innovations International -23.73%-26.77%-15.01%

Butterfly Network currently has a consensus target price of $5.56, suggesting a potential downside of 41.45%. SS Innovations International has a consensus target price of $7.00, suggesting a potential upside of 94.99%. Given SS Innovations International's higher probable upside, analysts clearly believe SS Innovations International is more favorable than Butterfly Network.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Butterfly Network
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40
SS Innovations International
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Butterfly Network has a beta of 2.09, suggesting that its stock price is 109% more volatile than the broader market. Comparatively, SS Innovations International has a beta of -1.92, suggesting that its stock price is 292% less volatile than the broader market.

Summary

Butterfly Network beats SS Innovations International on 10 of the 16 factors compared between the two stocks.

Get SS Innovations International News Delivered to You Automatically

Sign up to receive the latest news and ratings for SSII and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SSII and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SSII vs. The Competition

MetricSS Innovations InternationalHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$723.39M$5.89B$7.27B$12.76B
Dividend YieldN/A1.75%2.54%11.09%
P/E Ratio-59.8326.30270.6924.20
Price / Sales16.9380.78639.89109.39
Price / CashN/A33.2076.8953.23
Price / Book13.306.2013.436.37
Net Income-$12.13M$149.51M$3.46B$347.74M
7 Day Performance-7.71%0.87%2.15%0.06%
1 Month Performance0.28%8.29%6.18%2.86%
1 Year Performance-48.64%7.70%24.96%17.13%

SS Innovations International Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SSII
SS Innovations International
2.2514 of 5 stars
$3.59
-0.6%
$7.00
+95.0%
-52.4%$723.39M$42.49MN/A4
PLSE
Pulse Biosciences
1.3976 of 5 stars
$44.54
-0.8%
$41.00
-7.9%
+215.1%$3.11B$350KN/A140
TMDX
TransMedics Group
4.4256 of 5 stars
$88.58
-1.2%
$124.18
+40.2%
-20.2%$3.06B$668.47M22.77210
AXGN
AxoGen
2.6318 of 5 stars
$48.73
+1.4%
$51.00
+4.7%
+218.2%$2.58B$225.21MN/A450
ESTA
Establishment Labs
3.517 of 5 stars
$79.47
+5.1%
$100.25
+26.1%
+81.7%$2.37B$245.82MN/A1,004

Related Companies and Tools


This page (NASDAQ:SSII) was last updated on 8/22/2026 by MarketBeat.com Staff.
From Our Partners